Matches in Nanopublications for { ?s ?p "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP454820.RAlMEiRoiYXHpAt_UA3rwVOAdFKsGYA2ZQI-XWiQlemFg130_assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454820.RAlMEiRoiYXHpAt_UA3rwVOAdFKsGYA2ZQI-XWiQlemFg130_provenance.
- NP274261.RA_406-5lEXewToXCIQH1-mpiSVn2z99u91FnTj3HHx0g130_assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274261.RA_406-5lEXewToXCIQH1-mpiSVn2z99u91FnTj3HHx0g130_provenance.
- assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP826124.RAdFVKutRML_5_3H2GAU8weBDon4VmU0J3mP0SKmHsg_k130_assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826124.RAdFVKutRML_5_3H2GAU8weBDon4VmU0J3mP0SKmHsg_k130_provenance.
- NP826122.RANBwEBbNACZDj0CJueENPjx_5GNSxYvEaW-jCtfbYujw130_assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826122.RANBwEBbNACZDj0CJueENPjx_5GNSxYvEaW-jCtfbYujw130_provenance.
- NP274080.RAor4M0osc-zlL-EU8w7E02gnde_Dorp3ncOQWOod4rmE130_assertion description "[In support of this hypothesis, we observed that MDA-MB-231 human breast tumor cells engineered to overexpress EMMPRIN strongly induced osteolytic lesions in immunodeficient mice, which was blunted by in vivo treatment with an EMMPRIN blocking antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274080.RAor4M0osc-zlL-EU8w7E02gnde_Dorp3ncOQWOod4rmE130_provenance.